SYRE
Spyre Therapeutics Inc.
79.90$
-1.2%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.16 | 2.69 | 1.84 | 2.62 | 1.92 | 2.33 | 2.26 | 2.89 | – | – | – | – | – | – | – | – | – | – | – | 5.22 | 0.53 | 1.85 | 0.52 | 0.19 | 0.05 | 0.06 | 0.05 | 0.18 | 0.00 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.21 | 0.00 | 0.00 | 1.07 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 5.17 | 5.64 | 0.25 | 0.19 | 0.14 | 0.13 | 0.19 | 0.15 | 0.11 | – | 0.04 | – | – | – | – | – | – | 0.75 | 0.60 | – | – | – | |
| 2.16 | 2.69 | 1.84 | 2.62 | 1.92 | 2.33 | 2.26 | 2.89 | – | – | – | – | – | – | – | – | – | – | – | 0.04 | -5.11 | 1.59 | 0.33 | 0.05 | -0.09 | -0.12 | -0.09 | 0.18 | – | 0.00 | – | – | – | – | – | – | -0.75 | 0.60 | – | – | – | |
| 10.10 | 10.24 | 9.26 | 10.34 | 9.50 | 9.11 | 10.30 | 11.07 | 10.15 | 11.84 | 12.40 | 11.27 | 13.56 | 13.50 | 11.00 | 7.97 | 5.00 | 6.81 | 4.52 | 5.17 | 5.64 | 8.50 | 6.43 | 4.67 | 3.18 | 5.45 | 3.65 | 4.55 | 5.74 | 1.55 | 0.96 | 0.72 | 0.88 | 1.07 | 0.69 | 0.66 | 0.75 | 0.59 | 0.77 | 0.77 | 2.55 | |
| 3.87 | 4.42 | 4.42 | 4.19 | 4.60 | 3.64 | 4.33 | 3.55 | 3.77 | 3.52 | 2.82 | 2.90 | 3.27 | 3.34 | 3.37 | 2.22 | 2.28 | 3.04 | 2.42 | 2.60 | 2.60 | – | – | – | 1.85 | 1.94 | 1.39 | 3.16 | 2.00 | 0.65 | 0.35 | 0.25 | 0.21 | 0.23 | 0.20 | 0.19 | 0.19 | 0.17 | 0.19 | 0.19 | 0.66 | |
| 13.98 | 14.66 | 13.68 | 14.52 | 14.11 | 12.75 | 14.63 | 14.62 | 13.92 | 15.36 | 15.22 | 14.18 | 16.83 | 16.84 | 14.37 | 10.18 | 7.28 | 9.85 | 6.94 | 2.60 | 2.60 | 11.95 | 9.59 | 6.86 | 4.89 | 7.21 | 4.89 | 41.84 | 4.27 | 2.12 | 1.31 | 0.97 | 1.09 | 1.30 | 0.89 | 0.69 | 0.19 | 1.36 | 0.58 | 0.49 | 2.38 | |
| -11.82 | -11.97 | -11.84 | -11.90 | -12.18 | -10.42 | -12.36 | -11.74 | -13.92 | -15.36 | -15.22 | -14.18 | -16.83 | -16.84 | -14.37 | -10.18 | -7.28 | -9.85 | -6.94 | -2.55 | -7.71 | -10.35 | -9.26 | -6.82 | -4.98 | -7.33 | -4.99 | -41.66 | -4.27 | -2.12 | -1.31 | -0.97 | -1.09 | -1.30 | -0.89 | -0.69 | -0.94 | -0.76 | -0.58 | -0.49 | -2.38 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.45 | – | – | – | – | – | – | – | |
| -11.70 | -11.84 | -11.68 | -11.75 | -12.00 | -10.19 | -12.17 | -11.43 | -13.55 | -14.95 | -14.79 | -13.72 | -16.40 | -16.52 | -14.15 | -10.11 | -7.24 | -9.82 | -6.94 | -2.57 | -7.71 | -10.34 | -9.26 | -6.79 | -4.89 | -7.19 | -4.90 | -56.79 | -9.34 | -2.91 | -1.20 | -0.86 | -1.36 | -1.20 | -0.74 | -0.60 | -0.19 | -0.83 | -0.88 | -0.43 | -2.11 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.04 | 0.01 | 0.01 | – | 0.00 | -0.06 | 0.01 | -0.01 | 0.00 | 0.00 | -0.26 | 0.00 | – | 0.00 | 0.00 | 0.00 | – | – | 0.00 | – | – | – | |
| -11.70 | -11.84 | -11.68 | -11.75 | -12.00 | -10.19 | -12.17 | -11.43 | -13.55 | -14.95 | -14.79 | -13.72 | -16.40 | -16.52 | -14.15 | -10.11 | -7.24 | -9.82 | -6.94 | -2.60 | -7.72 | -10.36 | -9.26 | -6.79 | -4.84 | -7.20 | -4.89 | -56.79 | -9.34 | -2.91 | -1.20 | -0.86 | -1.36 | -1.20 | -0.74 | -0.60 | -0.19 | -0.83 | -0.88 | -0.43 | -2.11 | |
| -11.76 | -11.89 | -11.74 | -11.79 | -12.08 | -10.31 | -12.26 | -11.65 | -13.83 | -15.28 | -15.13 | -14.09 | -16.75 | -16.76 | -14.25 | -10.08 | -7.18 | -9.69 | -6.80 | -2.41 | -7.55 | -10.09 | -9.07 | -6.64 | -4.76 | -7.00 | -4.75 | -7.41 | -7.74 | -2.20 | -1.20 | -0.86 | -1.36 | -1.20 | -0.74 | -0.86 | -0.19 | -0.83 | -0.96 | -0.43 | -2.19 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.